Search
Zavolosotine
go.drugbank.com/drugs/DB21531ExperimentalZavolosotine has a monoisotopic molecular weight of 439.14 Da.
Branosotine
go.drugbank.com/drugs/DB21674ExperimentalBranosotine has a monoisotopic molecular weight of 471.22 Da.
S-3304
go.drugbank.com/drugs/DB12149InvestigationalS-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others
XL765
go.drugbank.com/drugs/DB05241InvestigationalXL765 is an orally available small molecule that has been shown in preclinical studies to selectively inhibit the activity of phosphoinositide-3 kinase (PI3K) and mammalian target of rapamycin (mTOR).
TAK-428
go.drugbank.com/drugs/DB05499ExperimentalIt is based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and regenerated by stimulating an increase in neurotrophic factors.
Reparixin
go.drugbank.com/drugs/DB12614InvestigationalReparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type
Onapristone
go.drugbank.com/drugs/DB12637InvestigationalOnapristone has been used in trials studying the treatment of Prostate Cancer, Recurrent Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer, and Progesterone Receptor Positive
Theralizumab
go.drugbank.com/drugs/DB15717InvestigationalAfter the first human trial, it was withdrawn due to severe toxicity (likely due to lymphopenia and human cytokine release).[A216527,A216532]
Viquidacin
go.drugbank.com/drugs/DB19549ExperimentalViquidacin has a monoisotopic molecular weight of 504.16 Da.
Galamustine
go.drugbank.com/drugs/DB21062ExperimentalGalamustine has a monoisotopic molecular weight of 303.06 Da.